Synthesis, characterization and preliminary in vitro antibacterial screening activity of metal complex derivatives of 2-[(5-styryl-[1,3,4]thiadiazol-2-ylimino)-methyl]-phenol  by Yousif, Emad A. et al.
Journal of Taibah University for Science 8 (2014) 26–30
Available  online  at  www.sciencedirect.com
ScienceDirect
Synthesis, characterization and preliminary in vitro antibacterial
screening activity of metal complex derivatives of
2-[(5-styryl-[1,3,4]thiadiazol-2-ylimino)-methyl]-phenol
Emad A. Yousif a,∗, Ahmed S. Majeed a, Nadia A. Salih b
a Department of Chemistry, College of Science, Al-Nahrain University, Baghdad, Iraq
b School of Chemical Sciences & Food Technology, Faculty of Science and Technology, Universiti Kebangsaan Malaysia, 43600 Bangi, Selangor,
Malaysia
Available online 2 October 2013
Abstract
Five new metal complex derivatives of 2-[(5-styryl-[1,3,4]thiadiazol-2-ylimino)-methyl]-phenol with the metal ions [Ni(II),
Cu(II), Zn(II), Cd(II) and Sn(II)] were prepared in alcoholic medium. The complexes were characterized quantitatively and quali-
tatively by micro elemental analysis, Fourier transform infrared spectroscopy, ultraviolet–visible spectroscopy, mass spectroscopy,
1H and 13C nuclear magnetic resonance, magnetic susceptibility and conductivity measurements. The spectral study showed that
all the complexes obtained as monomeric structures and the central metal moieties are four-coordinated, with tetrahedral geometry,
except for the Cu(II) complex, which had square planar geometry. In preliminary in  vitro  antibacterial screening, all the complexes
showed moderate activity against the bacterial strains tested, which was slightly higher than with the ligand.
© 2013 Taibah University. Production and hosting by Elsevier B.V. All rights reserved.
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Heterocyclic moieties are found in many compounds
that have biological activity that depends mainly on their
molecular structure [1]. 1,3,4-Thiadiazoles are interest-
ing compounds because of their important use in many∗ Corresponding author. Tel.: +964 7901782816.
E-mail addresses: emad yousif@hotmail.com,
emadayousif@gmail.com (E.A. Yousif).
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http://dx.doi.org/10.1016/j.jtusci.2013.09.003pharmaceutical, biological and analytical applications
[2,3]. Schiff bases, which are bimolecular condensation
products of primary amines with aldehydes, are valuable
intermediates in organic synthesis and in other applica-
tions [4]. They are aromatic aldehydes ortho-substituted
with a hydroxyl group, which initially raised the interest
of researchers because of their ability to act as biden-
tate ligands for transition metal ions [5]. Schiff bases are
also important because of their flexibility, their structural
similarity with natural biological substances and because
of the presence of imine (N CH ), all of which help in
elucidating the mechanism of transformation and racem-
ization in biological systems [6]. These compounds can
also act as ligands, increasing biological activity by com-
plexation [7]. Derivatives of 1,3,4-thiadiazoles have been
reported to have antimicrobial activity [8].
Thiadiazole derivatives have occupied a unique
position in medicinal chemistry. Molecules like
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hiadiazole-containing Schiff bases have been inves-
igated for their pharmaceutical activity [9], and the
aturally occurring B6 vitamins pyridoxine, pyrodoxal,
yridoxamine and codecarbaxylase contain a thiadiazole
ucleus [10]. As some drugs with a thiadiazole nucleus
ere once used in the chemotherapy of bacterial diseases
11], we decided to synthesize more potent molecules.
.  Material  and  methods
.1.  General  and  instrumental
All the reagents, starting materials and solvents were
urchased commercially and used without further purifi-
ation. The melting-points were measured on a hot-stage
allen Kamp melting-point apparatus. Elemental C, H,
 and S analysis was carried out on a Fison EA 1108
nalyser. The Fourier transform infrared spectra were
ecorded on an FTIR.8300 Shimadzu spectrophotometer
ith a CsI disc in the frequency range 4000–200 cm−1.
he ultraviolet–visible spectra were recorded on a Shi-
adzu UV–vis 160 A-Ultra-violet spectrophotometer
n the range 200–1100 nm. Magnetic susceptibility was
easured at room temperature on a Magnetic Suscepti-
ility Balance Bruke Magnet B.M.6. Conductivity was
easured on a WTW conductivity metre, and atomic
bsorption was measured on a Shimadzu 680cc-flame
pectrometer. The spectra of 1H and 13C NMR were
ecorded on a Jeol 400 MHz spectrometer with d6-
MSO as the solvent and tetramethylsilane, as the
nternal standard. Mass spectra were recorded on a
icromass UK Platform II LC–MS spectrometer.
.2.  Preparation  of  2-[(5-styryl-[1,3,4]thiadiazol-2-
limino)-methyl]-phenol
A mixture of 3-phenylacrylic acid (0.01 mol),
hiosemicarbazide (0.01 mol) and phosphorus oxychlo-
ide (5 ml) was heated under reflux for 3 h. Upon cooling,
istilled water (50 ml) was added to the mixture, and
eating under reflux was continued for another 4 h.
he reaction mixture was filtered and neutralized with
otassium hydroxide. Then, the precipitate was fil-
ered and washed with cold distilled water and finally
ecrystallized in a 2:1 ethanol:water mixture to obtain
-[(5-styryl-[1,3,4]thiadiazol-2-ylimino)-methyl]. In the
ext reaction, this compound (0.01 mol) and salicy-
adehyde (0.01 mol) were heated under reflux for 3 h
o obtain a yellow precipitate, which was filtered
nd crystallized from ethanol to give the 2-[(5-styryl-
1,3,4]thiadiazol-2-ylimino)-methyl]-phenol ligand forFig. 1. Structure of ligand (L) and the proposed structure of complexes
1–5 (M = metal).
further complexation with metal ions. The stepwise
preparation of the ligand is shown in Fig. 1.
2.3.  Preparation  of  complexes
An ethanol solution of the metal(II) salts nickel(II)
chloride hexahydrate, tin(II) chloride, copper(II) chlo-
ride dihydrate, cadmium(II) chloride dihydrate and
zinc(II) chloride was added to the ethanol solution of the
ligand in a 1:2 metal:ligand molar ratio. Then, the mix-
ture was heated under reflux for 30 min, and coloured
precipitates were obtained, which were filtered out,
washed with distilled water and finally recrystallized.
3.  Results  and  discussionThe purity of the ligand and the five complexes
obtained were checked by thin-layer chromatography
with silica gel-G as the adsorbent. The complexes
had sharp melting-points, indicating the isolation of
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Table 1
Melting-points, elemental analytical data (%) and m/z values of the ligand and complexes.
Compound Colour Melting-point (◦C) Elements (%) m/z
C H N S M (metal)
Ligand Yellow 112–114 65.97 (66.45) 4.33 (4.23) 14.00 (13.68) 9.99 (10.42) – 307.0
Ni(L)2 Blue 177–1179 30.25 (30.41) 1.34 (1.93) 6.55 (6.26) 4.44 (4.77) 8.45 (8.75) 670.7
Cu(L)2 Green 186–188 29.88 (30.20) 1.88 (1.92) 7.90 (6.22) 4.34 (4.73) 9.02 (9.40) 675.5
Zn(L)2 Yellow 189–191 30.18 (30.11) 1.83 (1.92) 6.55 (6.20) 4.33 (4.72) 9.55 (9.65) 677.4
Cd(L)2 Yellow 110–114 28.12 (28.16) 1.32 (1.80) 6.00 (5.80) 4.33 (4.42) 15.44 (15.52) 724.4
Sn(L)2 Yellow 199–101 28.02 (28.16) 1.90 (1.80) 5.55 (5.80) 4.20 (4.42) 15.56 (15.40) 730.7
cating deprotonation and complexation of the ligand
anion to metal ions. The 1H NMR spectra of the com-
plexes were somewhat similar to those of the ligand,
Table 3
Electronic spectral data for the ligand and complexes in ethanol.
Compound Absorption bands (nm) AssignedCalculated value are given in brackets.
relatively pure compounds. The micro-elemental anal-
ysis for C, H, N and S and the relative molecular masses
of the complexes obtained were in agreement with the
predicted formulae. The proposed structures of the five
complexes and the ligand are depicted in Fig. 1. The
melting-points, micro-elemental analysis and m/z  data
are given in Table 1.
The infrared spectrum of the ligand showed some
characteristic stretching bands at 1635 and 1116 cm−1
assigned to ν(C N) and ν(C O), respectively, which
were also present in the complexes. The exception was
that the ν(C N) of the complexes were shifted to a lower
wavelength number than the ligand, signifying that coor-
dination took place via  the nitrogen atom of the ligand
[12]. In addition, stretching of the metal–oxygen and
metal–nitrogen bands of the complexes, which appeared
in the lower wavelength region in the range 556–501
and 488–432 cm−1, also indicates complexation through
nitrogen and oxygen atoms from the ligand [13]. The
most important infrared data for the ligand and the com-
plexes are given in Table 2.
The ultraviolet–visible electron spectrum of the
ligand and the complexes in ethanol solution are shown
in Table 3. The acid had three bands at 212, 254 and
348 nm attributable to   →  *,   →  * and n →  *
electron transition, respectively. Table 3 shows that the
Table 2
Selected infrared data for the ligand and complexes.
Compound Wavelength (cm−1)
ν(C N) ν(C O) ν(M O) ν(M N)
Ligand 1635 1116 – –
Ni(L)2 1600 1124 511 488
Cu(L)2 1600 1122 505 482
Zn(L)2 1612 1109 501 432
Cd(L)2 1609 1110 510 443
Sn(L)2 1608 1121 556 481complexes with Ni(II), Cd(II) and Sn(II) had electron
transition similar to that of the ligand. In the complexes
with Cu(II) and Zn(II), the electron transitions of the
metal d  orbitals (d–d  electron transition) observed in
Ni(II) and Cu(II) were located in the visible region as
extra information. In Ni(II), the d–d  electron transition
appeared at 728 and 1322 (calculated) nm assigned to
the 3T1(F) → 3T1(P) and 3T1(F) → 3A2(F) transitions,
respectively [14]. For Cu(II), the bands at 440, 550, 680
and 904 nm were attributed to the ligand →  Cu (charge
transfer), 2B1g → 1A1g, 2B1g → 2B2g and 2B1g →  Eg
respectively [15,16].
The 1H NMR spectra of the complexes provide addi-
tional support for complexation. The 1H NMR spectra
of the ligand showed a sharp peak, δ(OH), at 9.90 ppm,
which was absent in the spectra of the complexes, indi-transition
HL 212, 254, 348  → *,  → *,
n → *
Ni(L)2 245, 349  → *, n → *,
728 (average), 1322 (calculated) 3T1(F) → 3T1(P),
3T1(F) → 3A2(F)
Cu(L)2 246, 348, 440  → *, n → *,
L → Cu (charge
transfer),
500, 680, 904 2B1g → 1A1g,
2B1g → 2B2g,
2B1g → Eg
Zn(L)2 250, 349  → *, n → *
Cd(L)2 252, 350  → *, n → *
Sn(L)2 240, 320  → *, n → *
E.A. Yousif et al. / Journal of Taibah University for Science 8 (2014) 26–30 29
Table 4
1H and 13C NMR data for the ligand and complexes in d6-DMSO.
Compound Chemical shift, δ (ppm)
1H NMR 13C NMR
N CH Aromatic OH N CH- Thiadiazole Aromatic
Ligand 7.39 (s) 8.23–9.09 (m) 9.90 111.12 87.70, 90.79 125.43–132.54
Ni(L)2 7.37 (s) 8.33–9.26 (m) – 112.68 87.67, 90.77 125.57–132.51
Cu(L)2 7.30 (s) 8.29–9.13 (m) – 110.86 87.68, 90.80 125.52–132.61
Zn(L)2 7.31 (s) 8.39–9.25 (m) – 111.48 87.63, 90.79 125.42–132.52
Cd(L)2 7.33 (s) 8.27–9.29 (m) – 112.33 87.62, 90.76 125.52–132.61
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Sn(L)2 7.32 (s) 8.31–9.11 (m)
, singlet; m, multiplet.
ith the occurrence of N CH and aromatic proton
ignals centering at δ  ≈  7.34 ppm and at 8.23–9.29 ppm,
espectively [17]. 13C NMR study also showed sim-
larities between the complexes and the ligand, with
he occurrence of N CH carbon signals centering at
 ≈  111.12 ppm and thiadiazole carbons signals center-
ng at δ  ≈  87.65 and 90.78 ppm. Moreover, the aromatic
arbon signals of both the complexes and the ligand
ere located in the down-field region in the range
25.42–132.61 ppm. There was no uncharacterized peak
n the 1H and 13C NMR spectra of the ligand or the com-
lexes, indicating the purity of the samples obtained.
he 1H and 13C NMR spectral data for the ligand and
he complexes are shown in Table 4.
Magnetic moment measurements are widely used to
tudy transition metal complexes, and these are given for
he complexes in Table 5. The magnetic properties are
ue to the presence of unpaired electrons in the partially
lled d-orbit in the outer shell of these elements. Mag-
etic measurements outline the electron state of the metal
on in the complexes. The magnetic moment value of the
omplex with Ni(II) was approximately 4.33 B.M. (Bohr
agneton) and inferred as paramagnetic; the geometry
f the nickel(II) metal centre was tetrahedral. The com-
lex with Cu(II) showed a magnetic moment value at
able 5
onductivity measurements and magnetic moments of the ligand and
omplexes in dimethylformamide.
ompound Conductivity
(S/cm)
Magnetic
moment
(B.M.)
Proposed
structure
igand – – –
i(L)2 25 4.33 Tetrahedral
u(L)2 17 0.80 Square planar
n(L)2 17 0.00 Tetrahedral
d(L)2 9 0.00 Tetrahedral
n(L)2 20 0.00 Tetrahedral110.57 87.67, 90.78 125.42–132.54
B.M., and the Cu(II) metal moiety exhibited square pla-
nar geometry [18]. The complexes with Zn(II), Cd(II)
and Sn(II) are diamagnetic, and no magnetic moment
was recorded. The molar conductivity measurements
(Table 5) showed that all the complexes were non-
electrolytic.
All the complexes were studied to determine their
metal:ligand ratio by Job’s method [19]. A series of
solutions was prepared with a constant concentration
(10−3 M) of the metal ion and the ligand. The ratio was
determined from the relation between the absorption of
absorbed light and the molar ratio. The metal:ligand ratio
was 1:2 for all the complexes and was similar to that in
the solid state. The spectral study showed that the com-
plexes had tetrahedral geometry, except for the complex
with Cu(II) (square planar). The proposed structures of
the complexes are depicted in Fig. 1.
Preliminary results for the in  vitro  antibacterial activ-
ity of the ligand and the complexes are shown in Table 6.
The compounds were screened for antibacterial activ-
ity against Staphylococcus  aureus, Salmonella  typhi  and
Escherichia  coli  strains by the inhibition zone method
with agar diffusion [20,21]. A standard 6.35-mm diam-
eter sterilized filter paper disc impregnated with the
compound (200 and 100 g/ml in DMSO) was placed on
an agar plate seeded with the test bacterial strains, and
the plates were incubated for 24 h at 37 ◦C. The activ-
ity was determined by measuring the diameter of the
inhibition zone (in mm). Streptomycin was used as the
standard control. The preliminary results showed signif-
icantly greater activity of the complexes than the ligand.
The activity of the complexes was nevertheless mod-
erate, even when higher concentrations were applied.
This may be due to the bulkiness of the molecules and
their complicated structure, which might restrict their
mobility to the target cell or active site, as all the com-
plexes were monomeric and four-coordinated metal(II)
moieties.
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Table 6
Preliminary in vitro antibacterial screening activity of the ligand and complexes.
Compound Inhibition zone (mm)
Staphylococcus aureus Salmonella typhi Escherichia coli
100 g 200 g 100 g 200 g 100 g 200 g
Ligand None 5–10 5–10 11–20 5–10 5–10
Ni(L)2 5–10 5–10 5–10 >20 5–10 11–20
Cu(L)2 11–20 11–20 5–10 11–20 11–20 11–20
Zn(L)2 None 11–20 5–10 5–10 11–20 >20
5–1
11–2
[
[
[
[
[
[
[
[
[
[
[
dophenylalanine, Asian Res. Publ. Netw. 4 (6) (2009) 39–42.Cd(L)2 11–20 11–20
Sn(L)2 11–20 5–10
4.  Conclusions
The ligand, 2-[(5-styryl-[1,3,4]thiadiazol-2-
ylimino)-methyl]-phenol, was coordinated with
five metal ions via  oxygen and nitrogen atoms to
obtain the corresponding complexes. All the complexes
were four-coordinated and had tetrahedral geometry,
except for the complex with Cu(II) (square planar). A
preliminary in  vitro  antibacterial study indicated that
the complexes had moderate activity against the tested
bacterial strains and slightly higher activity than the
ligand.
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